Recent News

• 11.18.2025 - BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights
• 11.12.2025 - BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
• 10.30.2025 - Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30
• 09.30.2025 - BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module
• 09.25.2025 - BullFrog AI and Sygnature Discovery Announce Official Sales Launch of BullFrog Data Networks™ to Global Biopharma Clients
• 09.23.2025 - BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar
• 09.08.2025 - BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration

Recent Filings

• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 10.24.2025 - 8-K Current report
• 10.10.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 10.09.2025 - 8-K Current report
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - DEF 14A Other definitive proxy statements
• 09.23.2025 - 8-K Current report